卖什么
Natural hydrogel to keep internal organs scar-free after surgery
商业模式拆解
买家：谁掌握预算？
未核实Orthopedic/hand surgeons and the practices or hospitals that stock surgical supplies (surgeon-facing product).
触发点：什么让他们现在购买？
Up to 40% of tendon repair patients face lifelong mobility limits from scar formation; surgeons want better post-operative mobility outcomes.
工作流：什么输入变成什么输出？
Surgeon mixes and applies blue ECM-based B3 GEL with a proprietary delivery system around the repaired tendon during surgery; gel separates tissue for 1-4 weeks then degrades.
经济账：省了什么，怎么收费？
未核实Per-procedure single-use gel and delivery system sold to surgical sites (inferred); site cites about 110k US tendon procedures per year as the market.
渠道：怎么接触到客户？
未核实Contact-led sales to surgeons ("bring the B3 GEL System to your practice"); Contact page only, no online ordering.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2022 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.